相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of Interleukin-1β Inhibition on Blood Pressure, Incident Hypertension, and Residual Inflammatory Risk A Secondary Analysis of CANTOS
Alexander M. K. Rothman et al.
HYPERTENSION (2020)
Global prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients
Jean Jacques Noubiap et al.
HEART (2019)
Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function
Ignatios Ikonomidis et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Angiotensin-(1-7), Adipokines and Inflammation
Deborah de Farias Lelis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
IL-1 Blockade Reduces Inflammation in Pulmonary Arterial Hypertension and Right Ventricular Failure: A Single-Arm, Open-Label, Phase IB/II Pilot Study
Cory R. Trankle et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness
Guanghong Jia et al.
HYPERTENSION (2018)
Inhibition of interleukin-1 suppresses angiotensin II-induced aortic inflammation and aneurysm formation
Kikuo Isoda et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
IL-1 Antagonism in Men With Metabolic Syndrome and Low Testosterone: A Randomized Clinical Trial
Fahim Ebrahimi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Low- and High-renin Heart Failure Phenotypes with Clinical Implications
Noemi Pavo et al.
CLINICAL CHEMISTRY (2018)
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
Mohammad H. Forouzanfar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Interleukin-1 Antagonism Decreases Cortisol Levels in Obese Individuals
Sandrine Andrea Urwyler et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure
Ratnadeep Basu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2)
Benjamin W. Van Tassell et al.
CLINICAL CARDIOLOGY (2017)
The Role of Aldosterone in Obesity-Related Hypertension
Wakako Kawarazaki et al.
AMERICAN JOURNAL OF HYPERTENSION (2016)
Interleukin-1 Receptor Activation Potentiates Salt Reabsorption in Angiotensin II-Induced Hypertension via the NKCC2 Co-transporter in the Nephron
Jiandong Zhang et al.
CELL METABOLISM (2016)
Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study
Benjamin W. Van Tassell et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2016)
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Mohammad H. Forouzanfar et al.
LANCET (2016)
ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis
Ana Cristina Simoes e Silva et al.
PHARMACOLOGICAL RESEARCH (2016)
RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients
Suman Srinivasa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Cardiac index assessment: Validation of a new non-invasive very low current thoracic bioimpedance device by thermodilution
Andrea Faini et al.
BLOOD PRESSURE (2014)
Oral administration of angiotensin-(1-7) ameliorates type 2 diabetes in rats
Sergio H. S. Santos et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques
Rodrigo A. Fraga-Silva et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Roles of Inflammation, Oxidative Stress, and Vascular Dysfunction in Hypertension
Quynh N. Dinh et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system
Robson A. S. Santos et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension induced by systemic inflammation
Kay L. H. Wu et al.
JOURNAL OF NEUROINFLAMMATION (2012)
An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect
Rodrigo Araujo Fraga-Silva et al.
CLINICS (2011)
Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)
Antonio Abbate et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis
Masaru Iwai et al.
HYPERTENSION RESEARCH (2009)
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Claus M. Larsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
C-reactive protein and the risk of developing hypertension
HD Sesso et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
K Maedler et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
分享论文
